84 related articles for article (PubMed ID: 28233633)
1. Clinical impact of circulating tumor cells and therapy response in pancreatic cancer.
Okubo K; Uenosono Y; Arigami T; Mataki Y; Matsushita D; Yanagita S; Kurahara H; Sakoda M; Kijima Y; Maemura K; Natsugoe S
Eur J Surg Oncol; 2017 Jun; 43(6):1050-1055. PubMed ID: 28233633
[TBL] [Abstract][Full Text] [Related]
2. Thoracic wall muscle metastasis from pancreatic cancer.
Shimizu K; Hashimoto D; Umezaki N; Nakagawa S; Yamamura K; Chikamoto A; Matsumura F; Baba H
Surg Case Rep; 2018 Jan; 4(1):12. PubMed ID: 29372347
[TBL] [Abstract][Full Text] [Related]
3. Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples.
Wang R; Nissen NN; Zhang Y; Shao C; Chu CY; Huynh C; Posadas EM; Tomlinson JS; Lewis MS; Pandol SJ
Front Physiol; 2022; 13():827531. PubMed ID: 35237181
[TBL] [Abstract][Full Text] [Related]
4. Editorial: The emerging role of liquid biopsy in gastrointestinal, pancreatic and liver cancers.
Iacob R; Paul D; Popescu I
Front Med (Lausanne); 2023; 10():1341739. PubMed ID: 38169840
[No Abstract] [Full Text] [Related]
5. Circulating tumor cells: clinical validity and utility.
Cabel L; Proudhon C; Gortais H; Loirat D; Coussy F; Pierga JY; Bidard FC
Int J Clin Oncol; 2017 Jun; 22(3):421-430. PubMed ID: 28238187
[TBL] [Abstract][Full Text] [Related]
6. Cytologic characteristics of circulating epithelioid cells in pancreatic disease.
Rosenbaum MW; Cauley CE; Kulemann B; Liss AS; Castillo CF; Warshaw AL; Lillemoe KD; Thayer SP; Pitman MB
Cancer Cytopathol; 2017 May; 125(5):332-340. PubMed ID: 28257167
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Wan JCM; Massie C; Garcia-Corbacho J; Mouliere F; Brenton JD; Caldas C; Pacey S; Baird R; Rosenfeld N
Nat Rev Cancer; 2017 Apr; 17(4):223-238. PubMed ID: 28233803
[TBL] [Abstract][Full Text] [Related]
8. Integrating liquid biopsies into the management of cancer.
Siravegna G; Marsoni S; Siena S; Bardelli A
Nat Rev Clin Oncol; 2017 Sep; 14(9):531-548. PubMed ID: 28252003
[TBL] [Abstract][Full Text] [Related]
9. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
10. Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
Groot VP; Rezaee N; Wu W; Cameron JL; Fishman EK; Hruban RH; Weiss MJ; Zheng L; Wolfgang CL; He J
Ann Surg; 2018 May; 267(5):936-945. PubMed ID: 28338509
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Chen J; Xiao-Zhong G; Qi XS
J Immunol Res; 2017; 2017():8282391. PubMed ID: 28265583
[TBL] [Abstract][Full Text] [Related]
12. Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy.
Kasuga A; Hamamoto Y; Takeuchi A; Kawasaki K; Suzuki T; Hirata K; Sukawa Y; Takaishi H; Kanai T
Cancer Chemother Pharmacol; 2017 Mar; 79(3):595-602. PubMed ID: 28236000
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
[TBL] [Abstract][Full Text] [Related]
14. Clinical prognostic value of circulating tumor cells in the treatment of pancreatic cancer with gemcitabine chemotherapy.
Wang X; Hu L; Yang X; Chen F; Xu H; Yu H; Song Z; Fei J; Zhong Z
Exp Ther Med; 2021 Oct; 22(4):1140. PubMed ID: 34504586
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells as prognostic marker in pancreatic cancer.
Yakar M; Etiz D
World J Clin Oncol; 2024 Feb; 15(2):165-168. PubMed ID: 38455127
[TBL] [Abstract][Full Text] [Related]
17. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review.
Ramírez-Maldonado E; López Gordo S; Major Branco RP; Pavel MC; Estalella L; Llàcer-Millán E; Guerrero MA; López-Gordo E; Memba R; Jorba R
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338919
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma.
Stosic K; Senar OA; Tarfouss J; Bouchart C; Navez J; Van Laethem JL; Arsenijevic T
Cells; 2023 Dec; 13(1):. PubMed ID: 38201207
[TBL] [Abstract][Full Text] [Related]
19. Mobilization of Circulating Tumor Cells after Short- and Long-Term FOLFIRINOX and GEM/nab-PTX Chemotherapy in Xenograft Mouse Models of Human Pancreatic Cancer.
Ito Y; Kobuchi S; Kawakita A; Tosaka K; Matsunaga Y; Yoshioka S; Jonan S; Amagase K; Hashimoto K; Kanda M; Saito T; Nakanishi H
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001741
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
